NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.
6A) and 2-DOG uptake assays (Fig. 6B), we showed there to be no significant increase in glucose uptake in response to insulin, although basal uptake remained unchanged. This suggests that only ...
To test whether soccer specific training was effective interval training, players ran in a specially designed dribbling track, as well as participating in small group play (five a side). Laboratory ...